Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy

BACKGROUND: The baseline tumor size (BTS) is a prognostic factor for patients with non-small cell lung cancer (NSCLC) who received immune checkpoint inhibitor monotherapy (ICI-mono). However, this relationship is not yet known in patients treated with ICI in combination with chemotherapy (ICI-chemo)...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehara, Yuji, Hakozaki, Taiki, Kitadai, Rui, Narita, Kosuke, Watanabe, Kageaki, Hashimoto, Kana, Kawai, Shoko, Yomota, Makiko, Hosomi, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902087/
https://www.ncbi.nlm.nih.gov/pubmed/35280320
http://dx.doi.org/10.21037/tlcr-21-815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902087/
https://www.ncbi.nlm.nih.gov/pubmed/35280320
http://dx.doi.org/10.21037/tlcr-21-815

Ejemplares similares